These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 34667120)
21. Genome-wide analysis of bivalent histone modifications during Drosophila embryogenesis. Cheng Q; Xie H Genesis; 2022 Dec; 60(10-12):e23502. PubMed ID: 36125264 [TBL] [Abstract][Full Text] [Related]
22. Chromatin signature of embryonic pluripotency is established during genome activation. Vastenhouw NL; Zhang Y; Woods IG; Imam F; Regev A; Liu XS; Rinn J; Schier AF Nature; 2010 Apr; 464(7290):922-6. PubMed ID: 20336069 [TBL] [Abstract][Full Text] [Related]
23. An epigenetic signature of developmental potential in neural stem cells and early neurons. Burney MJ; Johnston C; Wong KY; Teng SW; Beglopoulos V; Stanton LW; Williams BP; Bithell A; Buckley NJ Stem Cells; 2013 Sep; 31(9):1868-80. PubMed ID: 23712654 [TBL] [Abstract][Full Text] [Related]
24. The Mll2 branch of the COMPASS family regulates bivalent promoters in mouse embryonic stem cells. Hu D; Garruss AS; Gao X; Morgan MA; Cook M; Smith ER; Shilatifard A Nat Struct Mol Biol; 2013 Sep; 20(9):1093-7. PubMed ID: 23934151 [TBL] [Abstract][Full Text] [Related]
25. Bivalent genes that undergo transcriptional switching identify networks of key regulators of embryonic stem cell differentiation. Jeon AJ; Tucker-Kellogg G BMC Genomics; 2020 Nov; 21(Suppl 10):614. PubMed ID: 33208095 [TBL] [Abstract][Full Text] [Related]
26. Genome-wide positioning of bivalent mononucleosomes. Sen S; Block KF; Pasini A; Baylin SB; Easwaran H BMC Med Genomics; 2016 Sep; 9(1):60. PubMed ID: 27634286 [TBL] [Abstract][Full Text] [Related]
27. Bimodal quantitative relationships between histone modifications for X-linked and autosomal loci. Sadreyev RI; Yildirim E; Pinter SF; Lee JT Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6949-54. PubMed ID: 23564346 [TBL] [Abstract][Full Text] [Related]
28. Facilitating transcriptional transitions: an overview of chromatin bivalency in plants. Faivre L; Schubert D J Exp Bot; 2023 Mar; 74(6):1770-1783. PubMed ID: 36656009 [TBL] [Abstract][Full Text] [Related]
29. Bivalent histone modifications in early embryogenesis. Vastenhouw NL; Schier AF Curr Opin Cell Biol; 2012 Jun; 24(3):374-86. PubMed ID: 22513113 [TBL] [Abstract][Full Text] [Related]
30. Distinct features of H3K4me3 and H3K27me3 chromatin domains in pre-implantation embryos. Liu X; Wang C; Liu W; Li J; Li C; Kou X; Chen J; Zhao Y; Gao H; Wang H; Zhang Y; Gao Y; Gao S Nature; 2016 Sep; 537(7621):558-562. PubMed ID: 27626379 [TBL] [Abstract][Full Text] [Related]
31. Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer. Zaidi SK; Frietze SE; Gordon JA; Heath JL; Messier T; Hong D; Boyd JR; Kang M; Imbalzano AN; Lian JB; Stein JL; Stein GS Mol Cell Biol; 2017 Dec; 37(23):. PubMed ID: 28923849 [TBL] [Abstract][Full Text] [Related]
32. Differences among brain tumor stem cell types and fetal neural stem cells in focal regions of histone modifications and DNA methylation, broad regions of modifications, and bivalent promoters. Yoo S; Bieda MC BMC Genomics; 2014 Aug; 15(1):724. PubMed ID: 25163646 [TBL] [Abstract][Full Text] [Related]
33. Intragenic CpG islands play important roles in bivalent chromatin assembly of developmental genes. Lee SM; Lee J; Noh KM; Choi WY; Jeon S; Oh GT; Kim-Ha J; Jin Y; Cho SW; Kim YJ Proc Natl Acad Sci U S A; 2017 Mar; 114(10):E1885-E1894. PubMed ID: 28223506 [TBL] [Abstract][Full Text] [Related]
34. Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression. Kaukonen D; Kaukonen R; Polit L; Hennessy BT; Lund R; Madden SF BMC Med Genomics; 2020 Jul; 13(1):92. PubMed ID: 32620123 [TBL] [Abstract][Full Text] [Related]
36. Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells. Chapman-Rothe N; Curry E; Zeller C; Liber D; Stronach E; Gabra H; Ghaem-Maghami S; Brown R Oncogene; 2013 Sep; 32(38):4586-92. PubMed ID: 23128397 [TBL] [Abstract][Full Text] [Related]
37. Histone modifications and p53 binding poise the p21 promoter for activation in human embryonic stem cells. Itahana Y; Zhang J; Göke J; Vardy LA; Han R; Iwamoto K; Cukuroglu E; Robson P; Pouladi MA; Colman A; Itahana K Sci Rep; 2016 Jun; 6():28112. PubMed ID: 27346849 [TBL] [Abstract][Full Text] [Related]
38. A TET1-PSPC1-Neat1 molecular axis modulates PRC2 functions in controlling stem cell bivalency. Huang X; Bashkenova N; Hong Y; Lyu C; Guallar D; Hu Z; Malik V; Li D; Wang H; Shen X; Zhou H; Wang J Cell Rep; 2022 Jun; 39(10):110928. PubMed ID: 35675764 [TBL] [Abstract][Full Text] [Related]
39. Genes upregulated in the amnion at labour are bivalently marked by activating and repressive histone modifications. Mitchell CM; Hirst JJ; Mitchell MD; Murray HG; Zakar T Mol Hum Reprod; 2019 Apr; 25(4):228-240. PubMed ID: 30753586 [TBL] [Abstract][Full Text] [Related]
40. Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant. Denissov S; Hofemeister H; Marks H; Kranz A; Ciotta G; Singh S; Anastassiadis K; Stunnenberg HG; Stewart AF Development; 2014 Feb; 141(3):526-37. PubMed ID: 24423662 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]